Cancer
Malignant Esophageal Neoplasm
CI-CAN-00001127Explore in graph →
Top-level518 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001127Explore in graph →
Clinical trials
1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (169)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02292914 | Prospective Analysis of Robot-Assisted Surgery | unknown | N/A | 1,120 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT02457299 | Esophagectomy With or Without Prior Ischemic Gastric Preconditioning | terminated | N/A | 1 | Endeavor HealthOTHER | 1 | Aug 5, 2019 | clinicaltrials |
| NCT04032353 |
| Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy |
| unknown |
| N/A |
| 10,000 |
| Yanqing LiOTHER |
| 1 |
| Jul 25, 2019 |
| clinicaltrials |
| NCT02389751 | Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer | completed | Phase 1 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 24, 2019 | clinicaltrials |
| NCT03185988 | Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System | unknown | Phase 2 | 100 | Shen LinOTHER | 1 | Jul 19, 2019 | clinicaltrials |
| NCT01855854 | Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH | completed | Phase 2 | 54 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 5, 2019 | clinicaltrials |
| NCT02139488 | Organ Motion and Early Tumor Response Measurement | completed | — | 80 | The Netherlands Cancer InstituteOTHER | 1 | Jun 27, 2019 | clinicaltrials |
| NCT03081715 | PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer | completed | N/A | 16 | Hangzhou Cancer HospitalOTHER | 1 | Jun 12, 2019 | clinicaltrials |
| NCT03940976 | Afatinib in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification (ESCC-A01) | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Jun 11, 2019 | clinicaltrials |
| NCT02649361 | Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102) | completed | Phase 2 | 164 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jun 5, 2019 | clinicaltrials |
| NCT03927495 | KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 100 | Shanghai Chest HospitalOTHER | 1 | May 29, 2019 | clinicaltrials |
| NCT03584308 | Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal | completed | Phase 2 | 110 | Catalysis SLINDUSTRY | 1 | May 22, 2019 | clinicaltrials |
| NCT01498757 | Genome-wide Association Study | withdrawn | — | 0 | Samsung Medical CenterOTHER | 1 | May 21, 2019 | clinicaltrials |
| NCT01248299 | Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.(E-DIS) | terminated | Phase 2 | 105 | Centre Oscar LambretOTHER | 1 | May 16, 2019 | clinicaltrials |
| NCT02803281 | Assessment of Patient Frailty Prior to Thoracic Surgery | completed | — | 40 | University Health Network, TorontoOTHER | 1 | May 7, 2019 | clinicaltrials |
| NCT00601705 | Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | completed | Phase 2 | 61 | Case Comprehensive Cancer CenterOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT03922230 | Exploration and Verification of DNA Methylolation in Early Screening of Esophageal Cancer | unknown | — | 300 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Apr 19, 2019 | clinicaltrials |
| NCT03910634 | IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients | unknown | Phase 2 | 264 | Sun Yat-sen UniversityOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT03113214 | PET/CT-directed Hyperfractionated Radiation Dose Escalation in Esophageal Cancer | completed | N/A | 27 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT03122548 | Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers | terminated | Phase 2 | 5 | Aduro Biotech, Inc.INDUSTRY | 1 | Apr 4, 2019 | clinicaltrials |
| NCT00917462 | Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer | completed | Phase 2 | 35 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 27, 2019 | clinicaltrials |
| NCT00217581 | Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer | completed | Phase 2 | 39 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 26, 2019 | clinicaltrials |
| NCT00372450 | Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer | withdrawn | N/A | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 20, 2019 | clinicaltrials |
| NCT01490749 | Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer | completed | Phase 1 | 17 | Emory UniversityOTHER | 1 | Mar 15, 2019 | clinicaltrials |
| NCT01715233 | Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. | completed | Phase 2 | 27 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 15, 2019 | clinicaltrials |
| NCT02547142 | Early Integration of Palliative Care in Esophageal Cancer Patients | terminated | N/A | 12 | McMaster UniversityOTHER | 1 | Mar 14, 2019 | clinicaltrials |
| NCT03671642 | Perioperative Perfusion Measurement - a Feasibility and Usability Study | completed | N/A | 10 | Rigshospitalet, DenmarkOTHER | 1 | Mar 12, 2019 | clinicaltrials |
| NCT02812641 | Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC | unknown | Phase 2 | 50 | National Taiwan University HospitalOTHER | 1 | Mar 11, 2019 | clinicaltrials |
| NCT03857763 | A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 40 | Hebei Medical University Fourth HospitalOTHER | 0 | Feb 28, 2019 | clinicaltrials |
| NCT01831531 | Study of S-1 in Combination With Radiotherapy in Esophageal Cancer | completed | Phase 2 | 105 | Fudan UniversityOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT03833466 | Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo)(ECMTPneo) | unknown | Phase 2 | 15 | Peking UniversityOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT02353936 | A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus | unknown | Phase 2 | 30 | Yonsei UniversityOTHER | 1 | Feb 11, 2019 | clinicaltrials |
| NCT03787537 | Nutritional Status and Nutrient Supply in Hospitalised Surgical Patients | completed | — | 128 | Charite University, Berlin, GermanyOTHER | 1 | Jan 31, 2019 | clinicaltrials |
| NCT01372202 | CHFR Methylation Status Esophageal Cancer Study(J10130) | terminated | Phase 2 | 31 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03817567 | Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma | unknown | Phase 1 / Phase 2 | 50 | Sinocelltech Ltd.INDUSTRY | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03817658 | A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC | unknown | Phase 2 | 725 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03811379 | Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy | unknown | Phase 2 | 43 | Sun Yat-sen UniversityOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT02221245 | Wnt, Notch and Hedgehog Activity in Chemo-Naive Tumors Collected During Staging of Esophageal Cancer Patients | terminated | — | 24 | University of MiamiOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03804203 | Short Course Radiation Therapy in Palliative Treatment of Esophageal Cancer | unknown | N/A | 98 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03671265 | Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC | unknown | N/A | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jan 9, 2019 | clinicaltrials |
| NCT03234842 | Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal Cancer(ES01) | withdrawn | Phase 2 | 0 | University of FloridaOTHER | 1 | Dec 21, 2018 | clinicaltrials |
| NCT01386346 | Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer(VEOX) | completed | Phase 1 | 12 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 12, 2018 | clinicaltrials |
| NCT03731442 | Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients | recruiting | Phase 3 | 300 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 12, 2018 | clinicaltrials |
| NCT00493025 | Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery | terminated | Phase 2 | 19 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 6, 2018 | clinicaltrials |
| NCT03757754 | HPPH Photodynamic Therapy for Patients With Esophageal Cancer(HPPH) | unknown | Phase 1 | 30 | Zhejiang Hisun Pharmaceutical Co. Ltd.INDUSTRY | 1 | Nov 29, 2018 | clinicaltrials |
| NCT02960594 | hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse(TRT-001) | completed | Phase 1 | 93 | Inovio PharmaceuticalsINDUSTRY | 1 | Nov 19, 2018 | clinicaltrials |
| NCT03292757 | FLOTOR Pilot Study(FLOTOR) | completed | Phase 1 / Phase 2 | 21 | Oxford University Hospitals NHS TrustOTHER | 1 | Nov 19, 2018 | clinicaltrials |
| NCT01446874 | Prevention of Post-operative Pneumonia (POPP)(POPP) | terminated | Phase 2 / Phase 3 | 150 | Washington University School of MedicineOTHER | 1 | Nov 8, 2018 | clinicaltrials |
| NCT01262040 | Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive | completed | N/A | 154 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 7, 2018 | clinicaltrials |
| NCT03732508 | SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer | unknown | Phase 2 | 30 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Nov 6, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Aug 8, 2019source: clinicaltrials